Ebola Lethal Virus
November 4, 2013
Ebola, The Lethal Virus
Ebola has made its mark on the world over the past three decades. Since the first Ebola outbreak in 1976, numerous countries have come together in order to solve the mystery of the history of Ebola. Within a matter of days of symptoms presenting, the victims die an unimaginable death. Ebola is one of the most lethal viruses known to man with only one in every ten infected surviving (1). Key factors in understanding Ebola are its history, patterns, and the diagnosis and treatment of the disease. From 1976-79 two outbreaks of two different strains occurred simultaneously. E. Sudan was the first outbreak. It primarily revealed itself in …show more content…
This lead scientist’s to believe that the dead animals were responsible for the rapid spread of the virus. This outbreak was the first to be linked with animal mortality. During this outbreak of Ebola, over sixty gorillas and chimpanzees were found dead within the outbreak area. After further research, data proved that the mortality rate of animals in a certain population jumps just before an outbreak. This is based off of paw prints, broken vegetation, and excreta. Scientists currently agree that there is no conclusive explanation for what the host of Ebola is or where this virus originates. However, it is also agreed upon that the most likely species to be the reservoir of this lethal virus is the bat …show more content…
VSV causes symptoms consistent with foot and mouth, but not nearly as violent. It has proven effective in guinea pigs and mice. Along with Dr. Sullivan’s vaccine, it is effective in a month’s time. However, the VSV vaccine has risks. VSV has a record of causing illness in humans. If it is proven that the VSV vaccine is not pathogenic and does not release much of the virus into the host, then the vaccine may have a successful future (4). The Prime Boost Vaccine has passed the safety trials. The next step would be a field test in Africa. This would help demonstrate efficiency and effectiveness of the vaccine. Due to issues such as how to burry the dead has caused the relationships between the researchers and the locals to become tense. Therefore conducting a trial under these extraneous circumstances would be extremely difficult. During an outbreak in Gabon, an international team felt so threatened that they abandoned the affected town along with all of their research. WHO is trying to address these issues with African
Ebola, The Lethal Virus
Ebola has made its mark on the world over the past three decades. Since the first Ebola outbreak in 1976, numerous countries have come together in order to solve the mystery of the history of Ebola. Within a matter of days of symptoms presenting, the victims die an unimaginable death. Ebola is one of the most lethal viruses known to man with only one in every ten infected surviving (1). Key factors in understanding Ebola are its history, patterns, and the diagnosis and treatment of the disease. From 1976-79 two outbreaks of two different strains occurred simultaneously. E. Sudan was the first outbreak. It primarily revealed itself in …show more content…
This lead scientist’s to believe that the dead animals were responsible for the rapid spread of the virus. This outbreak was the first to be linked with animal mortality. During this outbreak of Ebola, over sixty gorillas and chimpanzees were found dead within the outbreak area. After further research, data proved that the mortality rate of animals in a certain population jumps just before an outbreak. This is based off of paw prints, broken vegetation, and excreta. Scientists currently agree that there is no conclusive explanation for what the host of Ebola is or where this virus originates. However, it is also agreed upon that the most likely species to be the reservoir of this lethal virus is the bat …show more content…
VSV causes symptoms consistent with foot and mouth, but not nearly as violent. It has proven effective in guinea pigs and mice. Along with Dr. Sullivan’s vaccine, it is effective in a month’s time. However, the VSV vaccine has risks. VSV has a record of causing illness in humans. If it is proven that the VSV vaccine is not pathogenic and does not release much of the virus into the host, then the vaccine may have a successful future (4). The Prime Boost Vaccine has passed the safety trials. The next step would be a field test in Africa. This would help demonstrate efficiency and effectiveness of the vaccine. Due to issues such as how to burry the dead has caused the relationships between the researchers and the locals to become tense. Therefore conducting a trial under these extraneous circumstances would be extremely difficult. During an outbreak in Gabon, an international team felt so threatened that they abandoned the affected town along with all of their research. WHO is trying to address these issues with African